Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 404 is a member of the zinc finger protein family, likely acting as a transcription factor that binds to DNA in a sequence-specific manner to regulate gene expression, specifically through RNA polymerase II-dependent mechanisms[1][4][8][9]. It is predicted to be active in the nucleus and is associated with differential expression patterns in many tissues[6]. Genetic variants near ZNF404 modulate its expression and have been associated with phenotypes like breast cancer susceptibility[2]. However, ZNF404 itself is not currently considered a direct therapeutic target. Disease associations include certain forms of deafness and arthrogryposis, with the most established role relating to modulation of gene expression and chromatin state[1][2][7].
Not applicable. No available drugs or therapies reported to target ZNF404 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 404 (ZNF404).